Transition Metal Macrocyclics as MRI Contrast Agents for Molecular Imaging
OwnerA B M Zakaria, Fahmeed Hyder +3inventors
InventorsA B M Zakaria, Fahmeed Hyder, Samuel Maritim, Jelena Milhailovic, Daniel Coman
Life of this patent
Estimating the term…
Loading patent…
OwnerA B M Zakaria, Fahmeed Hyder +3inventors
InventorsA B M Zakaria, Fahmeed Hyder, Samuel Maritim, Jelena Milhailovic, Daniel Coman
Estimating the term…
In one aspect, the present disclosure relates to a Magnetic Resonance Imaging (MRI) and Spectroscopic Imaging (MRSI) agent wherein the agent comprises a polyazamacrocyclic ligand coordinated to a first row transition metal ion. In another aspect, the disclosure relates to a method of using the MRI/MRSI agents of the present disclosure to monitor tissue temperature and/or pH in a patient in need thereof. In another aspect, the disclosure relates to a method of using the MRI/MRSI agents of the present disclosure to monitor the efficacy of a cancer treatment in a patient in need thereof.
A compound of Formula Ia or Formula IIa:
A method of monitoring at least one of tissue temperature and pH in a patient in need thereof, the method comprising:
A method of monitoring the efficacy of a cancer treatment in a patient in need thereof, the method comprising:
Dependencies are inferred from the claim text.